Peter MacCallum Cancer Centre at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Peter MacCallum Cancer Centre takes part in 2 sessions at ASH 2026 in New Orleans. Its program centres on treatment choices in diffuse large B-cell lymphoma and acute myeloid leukemia. It covers how to sequence bispecific antibodies in lymphoma and current approaches to AML through second-opinion case reviews.
| Organization | ASH 2026 Attendance |
|---|---|
Peter MacCallum Cancer Centre Melbourne, Australia | |
Public cancer hospital and research centre in Melbourne, Australia. | Symposium Fri Dec 11 7:00pm–10:00pm Advancing the DLBCL Paradigm: Sequencing Bispecifics in Optimizing Patient Care Where bispecific antibodies fit in diffuse large B-cell lymphoma, weighed against CAR-T by patient fitness, access, and T-cell health. Symposium Fri Dec 11 7:00am–10:00am Current Management Paradigms in Acute Myeloid Leukemia – A Second Opinion Case Review Difficult acute myeloid leukemia cases where doctors sought second opinions, paired with reviews of recent data, current management, and ongoing trials. |
Instantly find 20 buyers from Peter MacCallum Cancer Centre
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction